EE658 Cost-Effectiveness of Nivolumab in Combination With Platinum Doublet Chemotherapy (PDC) for the Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Slovenia
Abstract
Authors
S Radoš Krnel K Krnel E Grubar S Lucherini C Stanicel